
Aruba Networks Inc. (NASDAQ: ARUN) was raised to Outperform from Perform by Oppenheimer.
Avanir Pharmaceuticals Inc. (NASDAQ: AVNR) was raised to Buy from Neutral by Mizuho.
Avon Products Inc. (NYSE: AVP) was downgraded to Neutral from Buy at BTIG. Just on Thursday we noted that Avon was entering the second worst phase of a business ever — the questionable future phase.
Broadcom Corp. (NASDAQ: BRCM) was downgraded to Neutral from Buy at Nomura.
Control4 Corp. (NASDAQ: CTRL) was maintained as Buy with a $25 price target by Canaccord Genuity after earnings and guidance were called plain and strong. This remains an active pick of our own stocks that could double in 2014.
DirecTV (NASDAQ: DTV) was downgraded to Neutral from Buy at Citigroup.
ALSO READ: Is Sell in May and Go Away Right for 2014?
Endo International PLC (NASDAQ: ENDP) was raised to Overweight from Equal Weight by Morgan Stanley.
General Dynamics Corp. (NYSE: GD) was raised to Neutral from Sell with a $112 price target at Goldman Sachs.
LinkedIn Corp. (NYSE: LNKD) was raised to Buy from Neutral at UBS. Canaccord Genuity lowered its price target to $225 from $250.
Masco Corp. (NYSE: MAS) was raised to Neutral from Sell at Goldman Sachs, and it was raised to Strong Buy from Market Perform at Raymond James.
ALSO READ: Rite Aid Turnaround Back to 2001 Stock Prices
Monsanto Corp. (NYSE: MON) was started as Outperform with a $130 price target at BMO Capital Markets.
New Residential Investment Corp. (NYSE: NRZ) was reinstated as Outperform with a $7 price target by Credit Suisse.
Novartis A.G. (NYSE: NVS) was raised to Buy from Hold at Jefferies
OpenTable Inc. (NASDAQ: OPEN) was raised to Buy from Neutral at Bank of America Merrill Lynch.
Oracle Corp. (NASDAQ: ORCL) was raised to Buy from Hold at Societe Generale.
Sally Beauty Holdings Inc. (NYSE: SBH) was maintained as Buy but the price target was cut to $30 from $32 at Sterne Agee.
T-Mobile US Inc. (NYSE: TMUS) was reiterated as Buy at Canaccord Genuity after record additions.
United Microelectronics Corp. (NYSE: UMC) was downgraded to Neutral from Buy by UBS, but it was raised to Neutral from Underperform at Merrill Lynch.
Wynn Resorts Ltd. (NASDAQ: WYNN) was raised to Buy from Neutral and given a $260 price target by Sterne Agee.